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The cfl’ccte of SCVCFPI amphipathic psptidcs on HIV-1 production in pcrrirtcntly infccrcd cells arc described. M&tin. Y 26 amino asid @-h&al 
amphipathis pcptidc, rcducci HIV-1 production dor-dcpcndcntly. whetcar other mphiputhic peptides do not. Bix m&tin derivatives which rcurin 
the o-helical portion have similar effects ns mclittin, The reduction of viral infectivity is not due to an cffcst of mclittin on the virus partirler but 
to an intruccllulnr astion of the gcptidc, whick is randily t&n up into ccllr, ns rhown by quantitotivc ELISA. Western blots of cells from 
mclittin.trcatcd cultures uucst that lhc pressing of the w#pol precursor is impair& 
Amphipathic pcptidc: a-Helix; Mclittin; HIV-1: Asrrmbly 
1. INTRODUCTION 
In controlling the dcvclopmcnt of the acquired immu- 
nodcficicncy syndrome (AIDS) in persons infcctcd with 
the human immunodsficicnsy virus (HIV), it has bc- 
come a major aim to intcrfcrc with the production of 
ilfcctiaus HIV particles in the infected sells, One possi- 
ble strategy is to impair the budding and/or the tiscm- 
bly of the virus particle, stsps that involve interactions 
of viral proteins with the cellular membrane: the N- 
terminus of the gag precursor appears to be responsible 
for its membrane association [l], and the myristoylation 
of ths glycin at position 2 from the N-terminus is 
thought o play a major role in mcrnbranc anchoring [2], 
Howcvcr, other mechanisms of tnrgcting the gag prc- 
cursor to the ccl1 mcmbranc have also been discussed 
such as slcctrostatic interaction ktwccn gag and gp41 
[3] and formation of a coiled coil of the ~17 gag with rhc 
intracellular portion of gp41 [4], Because of this wide 
range of observed and postulated interactions bctwccn 
HIY proteins and the sellular membrane WC invcsti- 
goted whcthcr substancss with known membrane afin- 
ity, such as anphipathic pcptidcs, were able to reduce 
virus producticn. 
Because of its known amphiphilicity, which is com- 
bined with an a-helical conformation [5,6], and its mcm- 
brnnc affinity [7,8], mclittin was an interesting candi- 
date for testing the sffcct of a mcmbranc-active sub- 
stance on HIV production. Furthcrmorc, it has been 
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postulated thut mclittin exhibits tructural homology to 
the transmcmbranc part of the HIV glycoprotcin gp41 
[9]. Thus it sccmcd possible that mclittin might hinder 
the formation of infectious HIV particles by affcsting 
the correct formation of the viral envelops. 
HIV replication has marked influences on the rnaab- 
olism of the ccl1 mcmbranc and of second mesxngcrs 
[M-14] and mclittin in turn WY shown to interfere with 
second mcsscngw systems. possibIy due to its high affin- 
ity for calmodulin and scvcral cafmodulin-binding pro- 
teins [7,15,16]. So there wcrc three points - similarity 
to gp41, membrane interuction and intcrfsrencc with 
second messenger metabolism - which made it relevant 
to test the influence of mclittin on HIV production. 
In this paper, WC show that the amphipathic &helix 
of mclittin is able to reduce HIV-1 production in psrsis- 
tcntly infected KE37/1-IHI, cells and present data sug- 
gcsring that this is ashicvcd by interference of the mclit- 
tin with the processing of the gaglpol precursor protein. 
2. MATERIALS AND METHODS 
Human T lymphoma ccllr, uninfcctcd (KE37/1) and pcrmancn:ly 
infected with thr HIV-1 isnlatc HIV-III,, IKE37/1-III.11171 wcrc ob- 
I -~ “..~. 
taincd fram M. Pop&z (The Laboratory of Tumor Cell Biology, 
NCI, NH-I, Elcthcsda. MD, USA). Human fibroblastoid ccllr (LC5) 
susceptible to HlV infection were derived from human embryonic lung 
[18]. CSl66 T lymphoma cells [19,20] were used for HIV-1 titration. 
The cells wcrc cultivated in RPM1 1640 Medium !Ctihfn) supplr- 
mcntcd with NaHCO, (2,2 g/l), FCS (10%) and, in the cast of microtim 
trc cultures, with antibiotics (100 U pnicillin, 100 yg strcpromycin, 
nnd 0.25 yg Fungizone (Ampholcricin B, Gibco) per ml). Cells wcrc 
grown at 3% in a hl4mid !#tm@$%rc of 5% CO.. 
2.2. Syntfrcsis utuf purijication qfprpridcs 
The pcptidcs wcrc synlhcsizcd on the resin Ultrosyn C using the 
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Fmorstrutcgy and o linker rclcrrin& the psplidco us umida. SynlhCSis 
was arricd out on un uutomnlic prptidc xyn~hcskr (model Biolynx. 
Novrrbiorhromr. UK) xcording lo tbc inrlrucrionr or the munuhc- 
turcr. The pcptidcr wcrc puriilsd tin tl TSK 12OT reverse-phnsc eel- 
umn 7.5 x 300 mm (Phurmuciu Bioryrtcm uls, Dcamnrk). and the 
amine acid content wus vcrillcd by mnss spctromclry. All peptidcs 
urcd wcrc more than 95% pure. 
Ccllr wcrccultivatcd in microtitrc plnta. OndryO wushcd cells were 
sccdcd by dding 10 ~1 of u cell suspension ~1O’ccllr/ml) to ccll~frcc 
medium (POPI) containing lhc drug in the clpproprintcconccnlmtions, 
The final cullurc volume was drsigncd lo bc ICIO~I. If thcculturcs were 
to bt ~rcatcd rcpcurcdly, the Onul culture volume of IO0 ~1 wus 
uchicvcd with the Iart lrcatmcnt on day 4 or 7 after sltlrl ofcultivation. 
Rcpr;ltcd treatment WIS pcrformcd by feeding the cul~urcs cvcry 24 
h with IO )rl fresh medium. whcrc rhc uddcd medium contuincd ths 
subrtansc in a conccntrution which comp#lratcd for rhc growins 
culture volum, The rubdunces wcrc applied in conccntmlions be- 
tmcn 0.5 and 3Oc(glml dcpcndinn on their toxicity. Thccorrcrponding 
moluritics, assuming thut the rubstrnccs arc complctcly in free solu- 
rion. arc sivcn in psrcnthcscs nt Ihe proper plnccs. 
For the dctcrminalion of cell growth and viability (on duy 4 or 7 
after start of cultivation), the MlT test was cllrricd out in the microti- 
trc cultures according to Mosmrrnn [2l]. The tcsI was slightly modified 
in the following way: 10~1 of un M7T (3~(4,~~in~sthylthieruIc~2~yl)= 
2,S~diphcnyltctruxolimbromidc) solution (5 mylml MIT dissolved in 
PBS. und stcrilizcd by filtration) wcrc added to cvcry well. The cells 
wcrc incubated with the MTT for 4 Ir al 37-C in a 5% CO: ntmosphcrc 
to nllow MIT mcrrbalizxttion. The reaction WPS sroppcd by uddiny 
180 ~1 of 0.04 N HCI in iropropnnol to cvcry well and the dye was 
cxtrrctcd. The resulting solutions were vigorously mixed in order to 
dissolve all formmnc cryst111s. The optical density (OD) of the solu. 
tion was determined at A q 600 nm nnd corrcctccl lor blunk OD velucr 
(cell-free culture medium plus MlT and isopropanol). 
2.4. Dcrcrrninuriun a$ H/Y rrplicario?~ 
The production of infectious HIV in trcatcd infcctcdcclls was analy- 
ssd in gflrallcl to the cell Browth dcterminatian. Microtitrc culturcr of 
HIV-infected cells wcrc grown as dcssribcd above. On days 4 or 7, rhc 
microrirrc culrurcr wcrc pooled in duplicafcs (?OO@, 4.folJ) and the 
plates were fxntril’ugcd (IO min. 3,000 rpm), The cell-free rupcrnutantr 
wcrcuddcd to uninfected LCScclls(l00~l lo 3,000ccIl~wcll in 96 well 
plntu. 4 wcllr per drug concentration). The supcrnatants wcrc rc- 
moved from the LCS cells after I h incubation at 37.C and rcplnscd 
by fresh culture medium. AfIcr four days rhc infcctcd cells in the LCS 
cullurcs wcrc dctcrmincd by the indircsr irnmunopcroxidarc staining 
method (IPS) [22). The colonies of HW positive ccllr wcrc counted as 
infectious ccntrcs. The 4 different counls per drug doss wcrc avert@ 
and related to the OD vnluc of lhc corresponding lymphomu ccl1 
culture 8s obtained by the Mm &st. The result obtnincd is the ratio 
of infectious HIV perliclcs per vinblc. trcutcd T lymphomu cell. 
For the dctcrminnlion of rcvcrsc Iranucrip:arc acliviiy in rhc supcr- 
nalanfs of T lymphomu cultures. six 1 ml cultures wcrc pooled und 
centrifuged (10 min, 3.000 rpm), Halt’thc volume ol’u 30% PEG 6000 
solulion was olddcd and protein wus prccipitatcd ovcrnisht aI 4.C. The 
prccipitatcd protein was collcctcd by centrifugalion (20 min, 3,000 
rpm, 4.C) and tcstcd Ibr reverse rrnnccriptnsc activity us described 
clscwhcrc [23]. The rcvcrsc trimscriptasc activity (RT) vuluc was calcu. 
la~cd in cpm/ml supernalam and rclntcd to the OD value as obruincd 
by the MTT test of the corresponding T lymphoma ccl1 culture. 
The quantilativc HIV ~24 anligcn capture ELISA was obtuincd 
from DuPont and pcrformcd according to the munufacturcr’s instrue 
tions. The p24 amounts in tcstcd sopcrnatanrs wcrc normalirrd to the 
CCTT numhcr in ihc cuiiurc. 
2.5. ELBA for quuntitutivc dctcnrtitwtion 01 nwlittin 
Mclittin breakdown in ccllculturcs (LC5 ccllr) WPS measured by LLU 
ELISA. The medium und thccclls WC asstlycd scpnratcly. Briefly. the 
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medium war rcmuvcd frum the cells I’or cstimution of free mclittin und 
an crlwl volume of medium was uddcd lo Ihe rcmaininyccllr includiny 
2% Triton X. 100. The cclb wcrc ssrtqxd oTr in this burcr, lcl’t for I 
h ut 0-C und frozen. Triron X-100 was ttlro uddcd to Iht culmrc 
medium before this WILI frozen. All sub:cqucnt incubations with sum- 
plan wcrc curried OUI al O*C. 
The ELISA was 1 compctirion assay uing u solid phesc of mcliltin 
coupled N+crminally IO albumin. Mclitlin was coulkd to albumin 
(RIA grade. Siymu) Wry 2.5% glutnraldshydc in u borutc butTcr (50 
mM, pH 8.5) for 24 h followed by diulyris npinst the ELlSA coupling 
bufk. This ;rntiycn prcpirmtion was used us fhc lirsl layer in the 
ELISA (10 ~glwcll), 
The ELISA plaw wcrccoatcd overnight at 4.C with the first Iaycr, 
followed by blocking and washing with 0.1% ulbumin. 1% Twccn 20. 
50 mM KM:PO,. pH 7,s (washing buflcr). 
The second layer cons&cd of B polycloml antibody (dilution 
l:l&lO) to the amide end of mclirtin (ALK, Copenhagen). and the 
UrnpIe or standards ol’ mclittin (srmpla und blanks contained 2% 
Triton X-100). The bufTcr WI l%Twccn 20.50 mM KHIPOI, pH 7.S. 
The incubation WBS rYrricd out ovcrnighl nt 4.C. Then the wcllr wcrc 
wushcd 3 times with the washing bufl&. 
The third layer wus un anti-wbbit antibody coupled lo pero,xidasc 
(Daka. Copnhrasn) and inrubalbn wus I h, The pcroxidnsc rcuction 
WIU wrricd out lor 10 min by addition ol’substmtc (0.2 mlJml orrha- 
phcnylcnc diumins. 0. I% hydrolcn pcroxidc). The reaction wus tcrml- 
nutcd by additian of 100~1 100 mM H.&XI, und rcsulrcd in tin hsorp- 
lion of 0.1-1.2 units. 
Aliquols or RPM1 1640 medium containing mclitlin in conccntra- 
lions of 0,4 or lOfi#ml were prepared und kcpl ut 37.C for VilriOUS 
timer. tn u parullcl cxprlmcnl, uninfcctcd KE37/1 T lymphoma cells 
(ubout IOYml) wcrcaddcd tr) the mclit~insontuiningund thcmclittin- 
free medium. 
At time 0.3. 16.24 und40 h.rll incubated mcdium/mclittin ramplcs 
wcrc m;lde ccl1 free und uddcd to rrah HIV prcparalions (supcrnatrnt 
or KE3711.III,, cslls. conccntmtcd by ultrawntrifugation a1 120,000 
x g, 90 min over u 20% w/w sucrose cushion). The virus wns raw 
pcndcd and incubated for I h ut 37.C. Then the virua was titrutcd on 
C8166 cells in 96.well microrlfrc phtcs(4 x IO’ ccll9lOO)rl. dupliatc 
per dilution), either Immcdiatcly or fol!owingrnothcr ultrucentrifuga- 
lion which was designed lo rcmovc non-virus-bound mclittin from the 
sumplcs. Syncytiu formation wus cstimutcd 4-6 days after titmtion; 
syncyth wcrc checked for HIV pro&r by indirect immunopcroxi- 
drsr rtnining [22]. and only wells with HIV-positive syncytia wcrc 
cnnridcrcd positive. The titrc is aivcn us the ncgutivc logarithm of the 
highest dilution rcndcriny HIV-poritivc syncytin. titrc reduction is 
sivcn US the diffcrcncc bctwccn titrcs of mclittin-free and mclittin- 
contuinirq medium amrplcr. 
SDS-PAGE ond Wcacrn blolting was curried out according IO 
rtundard protocols, using a low-salt extraction bufkr and ummonium 
sulfate precipitation tbr the prcparution 41‘ cell extracts. Equal 
amounts of protein wcrc loildcd onlo Inner of 11% polyacrylamidc 
gclr, The blols wcrc sraincd with a human strum posilivc for HIV and 
dctrctcd with II second untibody coupled to alkelinc phosphaturc (re- 
uction substrak: NBT/BCIP). 
3. RESULTS AND DISCUSSION 
The effect of mclittin treatment of human KE37/1 T --- 
lymphoma cells pcrsistcnrly inlkted with HIV-i was 
tested in doses of 0.54 pglml. Melittin had no effect cm 
the growth of uninfected and HIV-1 infected T lym- 
p:ioma cells in conccntriltions from 0.5 to 2.5 &ml 
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Table I % [~24/oD] 
HIV inklivitiy (% HIV production) of su~rnatants following mclif- 
tin wwmcnl of the cullura (KE37/l.lllp sells: daily mclittln ICCM- 
mcnt): comparison of rvcnl cxpcrimcnls 
Mclittin concentration (rr#ml) 
0 0.5 1.5 2.5 3 4.5 5 
IExp, I 100 50 20 IOX. 
2;: ; 
LOO 80 IO t0x. 
loo 10 10X. 
i3xp. a I00 60 5 tax. 
(0.2-II,9 PM; rcpcatcd application), but was growth in- 
hibiting ut 5 &ml Cl,8 yM) tufter 4 doses within 4 days, 
There wus no difference in the growth inhibition of 
infected or uninfcctcd ccl1 lines (data not shown), Anal= 
ysis of the supcrnatants of the trcatcd lymphoma cul= 
turcs for infectious HIV showed already un almost total 
absence of infectious virus particles in the culture 
treated with 2,§&ml(OLIyM) and P 2040% reduction 
at 0.5 PgIrnl (0.2 PM), tls sscn in scvcral independent 
experiments (Table I). 
In order to test how long the dcscribsd effect of the 
mclittin can be measured nftcr mclittin application, WC 
grew lymphoma cultures which wcrc only muted onsc 
with mclittin and nnulyzcd on day 7. In thcsc cultures, 
mclittin had no cytatoxic effect on both uninfected and 
infected cells up to 8 rgIml(2.8 yM). Virus production 
(related to the corresponding ccl1 number) at this con- 
centration was 10% of the untreated infected cells (Fig. 
--%I=- supernatant (9 h) 
0 ougsrnatant (14 h) 
, . . , . . - 
0 5 10 MGtlln bgiml] IS 
Fig. 2. Quantitative dctcrmination of 824 in culture ovl>crnnrtant.s of 
KE37/lJllB following mclittin traimcnt in rcvcral concsntntions 
and at diffcrcnt times uftcr application of meliltin. The valuss arc 
normalizcd to lhc crll number and givsn in % (2 S.D.) of the talus 
of ths untrrrtcd control. Mclittin doer no1 disturb the quantilisation 
of p24 by ELISA (data not shown), 
1). Reverse transcriptasc activity in the suprnatants of 
mclittin-trcutcd cells declined in parallel with the dc- 
crcasc of production of infectious virus (Fig. 1). 
The reduction of HIV production by mclittin was 
further confirmed by quantitative mcasurcmcnt of HIY 
p24 in the supcrnatants of mclittin=trcatcd ultures. 3 h 
after mclittin upplication there was no reduction of p24 
in the culture supmutant even at 12 &TII (4.2 yM), 
a conccntrotion which is lytic to the cells in prolonged 
incubation. After 14 h, there is a marked reduction (70% 
% virus production&all number 
Table I1 
Log titrc rcduclion of HIV at various mcliltin cencsnrrations 
Prckxubetion time (h) Mclittin cencrntration 
4 relml 10 Wml 
0 0.5 2 0 Wml 
molitlln concsnfralion 
fig. 1. lnfcctious HIV production in psrmuncntly HIV-I infcst*d 
lymphoma cultures which had undsraonc ~i~~lc mclittin trcatmcnt (7 
days bcfors anaiysir). ?nc cullurc suprnalanu wcrcclisckd ior inlkc~ 
tious ccntrcs und for rcvcrsc transcriptasc activity (see Materials and 
Methods), Infectious virus (stippled bars) and rcvcrsc transcriptasc 
activity (hakhsd bars) arc given in 96 of ths values obtained with the 
supcrnatanls from unlrcatcd, infcctcd lymphomu control culturca. 
0 I 2 
+ n,d, n,d. 
3 OS 1.5 
+ 0 1 
16 0 0 
+ 0 I 
24 0 0.5 
+ 0 0 
40 n.d. n.d. 
+ 0 0 
‘iiii%%GriQiti EpSSiS ihiZWFT 1 lC,lY tiiiszd ziiiiiimi~;;-_,:cd 
virus preparations. 
-, prc.incubatlon i  ths abssncc of mslabelizing KE37/1 cclla 
*, prc.incubotion i  the prsssncs of metabolizing KE37/1 cells 
n,d., not dctcrmincd 
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of the value in untreated cultures) following single treat- 
ment with S ~(timl(2.8 PM) (Fig. 2). 
Since mclittin has been reported to be lytic to retro- 
viruses [24] and in higher concentrations i used to cx- 
tract rcvcrsc transcripturc from virus prcporntions [2S], 
we were interested whether the described reduction of 
HIV production in naslittin=treatcd cultures could be 
accounted for by a direst effect of the mclittin on the 
virus. This question was addressed by a set of cxpcri- 
mcnts determining the direct cffcst of mclittin on HIV 
inftcrivity. As shown in Table II, thcrc was no titrc 
reduction when melittin (4 pg/ml) was kept at 37OC in 
the prcscnce of metabolizing KE37/1 sells for 3 h or 
more. but a slight titrc reduction at 3 h when the melittin 
was kept in the absence of metabolizing cells, The same 
experiment done with a cytotoxic mclittin concentration 
of 10 &ml showed an enhanced titrc rcdustion when 
compared to the norxytotoxic conocntration (4 &ml). 
There was some differcnsc between mclittin kept in the 
presence or in the absence of metabolizing T lymphoma 
cells. After 40 h of pre-incubation o virolytic activity 
was left at all, 
To find out whether mclitcin is actually rcmovcd from 
the culture medium by the oclls, WC analyzed the prss- 
ence of melittin in LCS fibroblast cultures by quantita- 
tive ELISA. Fig. 3 shows that almost all rnclittin is 
removed from the medium within 2 h and found irr the 
ccl1 extract, whereas there is a quite long mclittin half- 
lift within the cells (about 24 h). This circumstance 
rcfleots our finding that the mclittin concentration toicr- 
ated by c&x is lower under daily treatment than single 
treatment (see Table I and Fig. 2 for a comparison) 
because a half-life of 24 h combined with total mclittin 
% InfMlcur crn~rrticall numbor % inttcliour cnnlrnakoll numbrr 
-da- Fglml (cells) 
I - kg/ml (medium) - 
0 
0 ICI 20 30 40 hours 50 
FiB. 3, Time dcpsndcncy or the disuppstrrnncc of m&tin Corn the 
medium (filled rymbolr) and the uglakc into nnd the dktppcarancc 
from the cells (open rymbols) after addition of 5 fig/ml of melittin nt 
c = 0 (mcarurcd by compclifion ELlSA), 
uptake allows an accumulation of mclittin under daily 
treatment. The long half-life of mclittin inside the cells 
could also ascount for the IongUting effect on HIV 
production. 
Sines the mclittin is so rapidly removed from the 
culture medium (Fig, 3) and since there is no MIV titrc 
reduction by mclittin cvcn at 10 yg/ml when kept in the 
200 
0 0 12 18 t@ml 
melilfin 1.20 conwn:ration 
-I 
20 30 pglml 
marloparan coneontrallon 
_-- 
Pig. 4, lnkctious kllY prosuction in HIY-1 inkctcd lymphoma cultures trcatcsi iaj with mciittin i-3 (amphipathic hciilrr oi’thc mciiuin withoui 
the carboxy.tcrminal basic hcxapcptidc) and (b) mastoparan. Dosage was rcpcatcd cvcry 24 h for 5 days. Determination of the infcctiour ccntrcs 
was done as described in Materials and Methods. Infcclious ccmrcs (about 100 wcrc obtained with supcrnatant from untrcatcd, infected lymphoma 
cultures) wcrc counted, avcrilgcd and related IO the ccl1 dcnsitics oblaincd from the MTT te51. This ralio of infcsrious ccntrcs to virutipraducing 
cells ia given in 96 (* SD,) of the value obtained wilh supcrnulonts from untrcatcd infcctcd lymphoma control cultures, 
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prcscncs of cells for 24 h or more (Table II), the virolytic 
ability of mclittin cannot account for the reduction of 
infcctiour virus psrticlcs found in cultures of chronically 
HIV infected KE37/1 c&s when treated with rnelittin 
(Table I and Fig. I), whcrc analysis for infectious virus 
was pcrformcd bstwccn 24 h and 7 days after the last 
trcatmcnt with mclictin. 
We thcrcfore supposed nn intracslluler ather than a 
mcmbranolytic cffcct to bc responsible for the dsscribcd 
observations. Since the membranolytic effect is mcdi- 
atcd by the basic carboxy-terminal hcxapcptidc at the 
tail of the melittin [26,27], we tcstcd a m&tin dcrivativc 
consisting only of the amino-terminal helix-forming 20 
amino acids (designated ‘mclittin l-20’). This substance 
was less toxic thnn mclittin 11s it is tolerated by the 
lymphoma cells up to 12 ,uglml(S,9~M) after rcpeatcd 
trcatmsnt. 18 ,u#ml of mclittin l-20 (8.9 PM) arc 90% 
growth inhibiting. At conccntrirtions of 6 and 12 pg/ml 
(3 and 5.9@4) of mclittin l-20 ths HlV production wus 
rcduccd to about 20% of the lcvcl in untreated cultures 
(Fig. 40). 
The comparison of mclittin and mclittin l-20 (Table 
I and Fig. 4a) showed that the cnrboxy-terminal toil 
(Lys-ArpLys-Arg-Gin-Gin) seems to modulats the cf- 
fcctivc concentration of the pcptidc, however, it dots 
not affect he principal action of the substance. In order 
to further analyze this phcnsmcnon, and possibly find 
substances cvcn more active than mclittin, WC synthc- 
sized a set of mc!i::in dtrivntivcs with diffcrcnt carboxy= 
terminal tails attached to the a=hclix. Our strategy was 
to design trails with different characteristics in their 
chorgc distributions, bcceusc the high positive charge in 
the ttril of native mclittin is rcsponsiblc for the intcras- 
tion with membrane phospholipids and conscqucntly 
the mcmbranc affinity [27], so dcrivativcs with altcrcd 
tail structures might exhibit altered mcmbmnc affinities 
and altered effects on HIV production. WC synthesized 
mclittin derivative with the following modified car- 
boxy-terminal tails: (i) six glycincs, ‘mclittin E’, (ii) orni= 
chin-ornithin, ‘mclittin F’, (iii) native sequence in IS 
conformiltion, ‘melittin 3’. (iv) Lys-Arg-Lys-Arg-Gly= 
Gly. ‘mclittin 4’. (v) four lysincs, ‘mclittin 6’. The effects 
of thcsc dcrivativcs arc summarized in Table IIIa. Mc- 
littin E (six glycincs) and mslittin 6 (four lysincs) had an 
effect compurirblc to mclittin l-20, the no=taii a-helix, 
indicating that the charge distribution within the tail 
alone does not explain the effect of mclittin on HIV 
production. The substance with D-amino acids (mclittin 
3) had a slightly reduced cffcct when compared to mclit- 
tin, whereas mclittin 4 (only the last two glutamincs 
were substituted by glycincs) had a stronger effect than 
nntivc mr’ittin on HIV production. Taken togcthsr, the 
Table Illa 
Effect of mclittin tail derivatives on the supcmetnnt infectivity of cul~urcs trcakd with subtoxic aubrtansc 
conccntmtlons 
Pcptidc Helix Tail Cons, Infectivity 
luM) (%I 
Mclittin 
Mclittin I-20 
Mclittin E 
Mclitrin F 
Mclittin 3 
M&tin 4 clittin 6
GIGAVLKVLTTGLPALlSWI KRKRQQ 
Y none 
II GGGGGG 
II Om-Orn 
II 
II 
E$;;;;QP) 
KKKK 
0.9 
: 
:*‘: 
I:3 
30 
40 
2.1 30 
0.6 4 7 5: 
Table fflb 
Effect of other amphiprthic pcptidn on the supcrnatant infectivity of cultures treated with subtonic substance 
concsntrationr 
Pcptidc Scqucllcc Cone. (CIM) Inkctivity (%) 
_ 
@I transmcmbrnnc FIMlVGOLYGLRIVFAVLSIYNRYRQG 10.3 loo 
MMC class 1 tmnsmcmbmnc VAAKANRYADEIRHKREKLE 19.3 
Mastoparan INLKALAALAKKlL 13.5 1: 
Table tIIc 
Effect of a non-amphipathic pcptidc (ncgutivc ontrol) on the supcrnatant infectivity of cultures trc;itcd with 
aubtanir substance concentrations 
Pcptidc Squcncc 
Gastrin rclc~sing factor pptidc FAE!ZGVDTPVFNSY 
Cont. @M) Infectivity (%,) 
29.4 100 
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data suggest hat the positive charycs in the tail influ- 
ence the inhibitory effect on HIV-1 production but also 
that other tail constructions can give a similar result. 
Sinsc the amphiputhic hclirr of the mclittin seems to 
bc sufftcicnt for the inhibition of HIV production, wc 
synthesized other cx-hcticcs that could cxcrt similar cl’= 
fccts, WC tcstcd mastoparan, the wasp venom pcptidc 
[71. which is nn umphiputhic a-helix of 14 amino acids. 
Mastoparnn was not toxic to the tymphomcl ells up to 
20 /g/ml (13.5 PM) and had no influence on the HIV 
production in this concentration. 30 AgIrnl (20.3 PM) 
wcrc 80% growth inhibiting und did not have 5~ signifi- 
cant influcncc on the HIV production in the surviving 
cells (Fig. r)b and Table 1Ilb). An omphipathic pcptidc 
from the transmcmbrunc portion of the MHC classs I 
protein did not intlucnce HIV production either (Table 
IIlb). nor did a non=umptriputhic ncgativc ontrol pcp- 
tide from the gastrin rclcasing factor (Table 111~)~ 
As indicated above. one of the reasons to test mclittin 
was its similarity to tramsmcmbranc regions of gp4l. WC 
synthesized a pcptidc from the gp41 transmsmbranc 
region and tested it in our system. However. there was 
no effect on HfV production in the concentrations 
tested (up to 10 PM; Table IIIb), A summsry of the 
tcstcd amphiputhic pcptidcs other than mclittin-dcri= 
vms, not inhibitory to HIV production. is given in 
Table IIIb. 
To further investigate a possible intracellular effect of 
melitrin on HIV production, WC nntltyred the apcctrum 
of HIV proteins in the cxtrtlrt of mclittin-trctltcd cells 
by Wcstcrn blotting using a human serum which reacts 
with all known HIV-1 structural proteins. Fig. S shows 
u Western blot where a 31 kDa protein is reduced fol- 
lowing D single mclittin treatment. This protein might 
correspond to the p31 intcgrasc. or to smc intcrmcdi- 
ate fragment of the processed gag/p01 precursor 
polyprotcin. WC arc in favour of the latter, since the 
high molecular weight bands arc more prcvalcnt in the 
extract of the treated cells. suggesting that the proccss- 
ing of the gag/pot precursor is impaired and immacurc 
cleavage products are cnrichcd under mclittin treat- 
ment. 
WC conclude that the inhibition of HIV-I production 
by mclittin, as described in this letter. is mediated by the 
umphipathis a-helical part (amino acids I-20) of mclit- 
tin as a result of intracellular impairment of HIV pro- 
tein production rather than a membrane ffect. This is 
suggested by thr observations that (i) mclittin is readily 
taken up into cells and (ii) a mctitrin derivative lacking 
the basic carboxy-terminal hcxapcptidc, which is rc- 
quircd for lytic activity [26,271, has a similar inhibitory 
effect on HIV-I as the melittin, albeit at somewhat 
higher conccntrarions: Ths sxprimsntFf with mste- 
paran and other a.hclical amphipathic pcptidcs show 
that the inhibition of HIV-1 production cannot be 
achieved just by any nmphipnthic o-helix. This fact sug- 
gests that thcrc arc some structural requircmcnts for 
240 
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iii 
30kB - 
2QkD - 
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Fiy. 5. Wcrurn blot of the cxtrws nT un~rciwl cells (I&) tend ccllr 
thet bud undcreonc sin&z mclirtin trcutmcnt (3 cI&Irnl) 3 days bcforc 
cxtrect prepntion. Sttlining wns perfanned with n human HIV-por- 
it&e swum. 
HIV inhibition which arc fulfilled by molittin but not 
other amphipnthic hclices. 
At the moment, WC speculate that mclittin interferes 
with the processing of the gag/pot precursor protein. 
This concept is strongly supported by reports that cnlm- 
odulin is n ccltuiur substrate of the HIV protcosc [28,291. 
Since mclittin is also known to have high affinity for 
calmodulin [7,8], n considcrabls affinity of mclittin for 
the vi& substrate of the HIV protcasc, the gndpol 
precursor, is likely. So mclittin might bind to the gaS/pol 
precursor thus preventing its being processed by the 
HIV protcasc. 
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